AI Article Synopsis

  • A new electrochemical immunofiltration analysis has been integrated into microfluidic paper-based analytical devices (μPADs) using advanced printing technologies, which improves detection methods for biological samples.
  • The device employs hydrophilic screen-printed electrodes biofunctionalized with capture antibodies, gold nanoparticles for signal amplification, and uses differential pulse voltammetry for sensitive electrochemical response measurement.
  • It successfully detected human chorionic gonadotropin (HCG) in a linear range of 1.0 to 100.0 IU/mL with a low detection limit, showcasing its potential for affordable and effective point-of-care testing in healthcare settings.

Article Abstract

An electrochemical immunofiltration analysis was introduced into microfluidic paper-based analytical devices (μPADs) for the first time, which was based on photolithography and screen-printing technology. The hydrophilic test zones of the aldehyde-functionalized screen-printed electrodes (SPEs) were biofunctionalized with capture antibodies (Ab). A sensitive immune detection method was developed by using primary signal antibody functionalized gold nanoparticles (GNPs/Ab) and alkaline phosphatase conjugated secondary antibody (ALP-IgG). Differential pulse voltammetry (DPV) was performed to detect the electrochemical response. The microfluidic paper-based electrochemical immunosensor (μ-PEI) was optimized and characterized for the detection of human chorionic gonadotropin (HCG), a model analyte, in a linear range from 1.0mIUmL to 100.0 IU mL with a detection limit of 0.36mIUmL. Additionally, the proposed μ-PEI was used to test HCG in real human serum and obtained satisfactory results. The disposable, efficient, sensitive and low-cost μ-PEI has exhibited great potential for the development of point-of-care testing (POCT) devices that can be applicated in healthcare monitoring.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bios.2017.02.002DOI Listing

Publication Analysis

Top Keywords

electrochemical immunofiltration
8
immunofiltration analysis
8
human chorionic
8
chorionic gonadotropin
8
microfluidic paper-based
8
paper-based microfluidic
4
microfluidic devices
4
electrochemical
4
devices electrochemical
4
analysis human
4

Similar Publications

Article Synopsis
  • A new electrochemical immunofiltration analysis has been integrated into microfluidic paper-based analytical devices (μPADs) using advanced printing technologies, which improves detection methods for biological samples.
  • The device employs hydrophilic screen-printed electrodes biofunctionalized with capture antibodies, gold nanoparticles for signal amplification, and uses differential pulse voltammetry for sensitive electrochemical response measurement.
  • It successfully detected human chorionic gonadotropin (HCG) in a linear range of 1.0 to 100.0 IU/mL with a low detection limit, showcasing its potential for affordable and effective point-of-care testing in healthcare settings.
View Article and Find Full Text PDF

Highly pathogenic avian influenza (HPAI) virus of the H5N1 subtype has caused devastating damage to poultry flocks and sporadic human H5N1 infections. There is concern that this virus subtype may gain transmissibility and become pandemic. Rapid diagnosis and surveillance for H5N1 subtype viruses are critical for the control of H5N1 infection.

View Article and Find Full Text PDF

An enzyme-linked immunofiltration assay (ELIFA) has been developed in order to estimate directly and specifically Thiobacillus ferrooxidans attachment on sulfide minerals. This method derives from the enzyme-linked immunosorbent assay but is performed on filtration membranes which allow the retention of mineral particles for a subsequent immunoenzymatic reaction in microtiter plates. The polyclonal antiserum used in this study was raised against T.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!